Dimension Capital, a wealth management firm, Founders Fund, a venture capital firm, and Kleiner Perkins, a venture capital firm, led a $40m Series A round in NewLimit, a biotechnology company, with participation from from Eric Schmidt, Elad Gil, Garry Tan, and Fred Ehrsam. "This new funding is in addition to the founders’ original $110 million commitment to the company. With the additional capital we plan to remain a small focused team where everyone contributes to the line work and everyone contributes to company building. There are no shortcuts." NewLimit press realese.